Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (4) , 711-714
- https://doi.org/10.1016/s0015-0282(01)03246-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UKHuman Reproduction, 2001
- A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon®) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulationHuman Reproduction, 1999
- Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproductionHuman Reproduction, 1999
- O-112. An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum β 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF/ICSI treatmentHuman Reproduction, 1999
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997
- O-108. A randomized prospective study of the effect of LH on follicular growth and developmentHuman Reproduction, 1997
- Publication bias in clinical researchThe Lancet, 1991